Below, a seven-step approach for engaging patients in research and codesigning a PEP is presented. A fillable PEP template is provided (Figure 2), while a fully worked example from 1 year of our trial is provided in Table 1. Note that in Table 1, we have used the position of the team member to indicate which team member is responsible for each activity and we indicate researcher time by initials. In cocreating PEPs within teams, however, we recommend identifying specific team members responsible for activities by name.
It is important to note that references to the ‘research team’, acknowledge patients as full partners on the team. The language of ‘researchers’ and ‘patient partners’ is not meant to imply a ‘we’ versus ‘them’ attitude; rather, it is used to clearly delineate the roles and responsibilities of all team members. Note also, that while a seven-step approach is presented, the development of the PEP was not linear. It involved multiple iterations amongst patient partners and researchers, with several drafts specifically informed by patient partners' requests (e.g., information on approximate time commitment or whether training was necessary for a given activity). Throughout the year-long development of the PEP, the process was presented at multiple national patient partner council meetings and national research team meetings so team members from other provinces could learn from NL efforts. The plan has been well received, and a second site (AB) recently used the template to create its specific provincial PEP. Patient partners have also shared the plan with other research teams with which they work. It was this transferability that led to our decision to publish the process and plan so other research teams could benefit.
3.1 A seven-step approach 3.1.1 Step 1: Choose a frameworkAt this stage, project researchers and the lead patient partners must decide how they want to engage patients in the research. Using an established patient engagement framework can be an important first step, as this helps shape the approach to patient engagement, clarify its goals and the scope of patients' involvement in the research project. The IAP2 Spectrum of Engagement modified for research16 was chosen for this study, as it clearly identified levels of patient involvement (Figure 1) and what the promise as researchers would be to patient partners. It also provided a clear degree of choice to patient partners in how they wished to be involved in specific project activities. This was particularly important, not only because the choice of involvement is the best practice for patient engagement3, 5, 8 but also because patient partners and researchers struggled with the exact nature of engagement for any given project activity. Using the levels of involvement in the research-modified IAP2 spectrum helped all team members critically reflect on what levels of involvement were possible for each project activity and what the responsibility of each team member would be at any given level.
There are a variety of tools and frameworks in the literature to help plan patient engagement activities in research.1, 2, 5, 23 Any of these can be useful guides for research teams, particularly those new to patient engagement as all provide a systematic way of considering the myriad choices to be made in engaging with patient partners in research. However, to our knowledge, there is no consensus in the literature on the ‘best’ tool or framework to use.
The steps that follow remain relevant to any framework that explicitly includes consideration of the levels of patient engagement.5, 23 For our purposes, we wanted to be as concrete as possible about each and every project activity that could benefit from patient engagement and at what level engagement was possible. The IAP2 spectrum modified for research16 allowed us to be explicit about these considerations, and its careful delineation of researcher commitment at each level also prompted us to consider what the parallel commitment for patient partners would be. This specificity proved to be very important to all team members and allowed patient partners to choose at what level they wished to engage in any project activity.
3.1.2 Step 2: Decide which parts of the project need patient engagementThe research team, including all patient partners, needs to review the major project activities and decide where patient input is most needed. For example, project management and execution will include activities, such as participant recruitment, data collection, data analysis and results interpretation. Even within these activities, there are subactivities (e.g., survey development, interview guide development, data entry and analysis and reporting). It is important to list each specific project activity and subactivities.
A useful starting point for identifying project activities is to review the project Gannt chart if one exists. The Gannt chart is an important project management tool and clearly outlines all project activities, when in the project lifecycle they should occur, and how long they should take. The team (including the province's three patient partners) began developing the PEP for the low-back pain project by reviewing the project activities outlined for the first calendar year of the project and selecting the activities that would benefit most from patient engagement. This level of project activity specificity is very important to patient partners. For example, at the time of starting to create our PEP, there were three main project activities remaining in that year. These included: dissemination of results for the qualitative phase of the study, developing the intervention to be used in the trial and developing the materials to be used in the trial intervention.
Other project activities may also be outlined in the Gannt chart (e.g., project administration) that are not included in our PEP. Regular and ongoing discussion with our patient partners during council meetings revealed their general lack of interest in these activities; as such, they are not included in our final PEP. However, at this stage, patient partners can suggest other activities that come to mind that may not be included in the original project plan. In our project, for example, patient partners acknowledged that they did not want to be involved in weekly operational meetings where site leads discussed new hires, new students or human resource issues. However, in discussion with site leads, they asked to be kept informed of news arising from operational meetings; as such, the team agreed to a weekly email of bulleted points summarizing these discussions.
3.1.3 Step 3: Select potential levels of patient engagement for each project activity requiring patient engagementOnce the team decides on the activities of the project that require/would benefit most from PE, careful thought is needed about at what level engagement can be offered, for each project activity. At this stage, select as many levels of engagement as possible to ensure opportunities for higher levels of engagement are not lost. At this point, it is important to address any feasibility considerations. The team must consider time, resources, supports or training required for patients and researchers at each level of the engagement plan, and who will coordinate this study. Higher levels of engagement will necessitate more resources and a greater need for facilitation and general coordination (see Table 1 below for specific examples). This step in the process should be completed in consultation with a patient engagement expert who can advise the team on the nuances of how to operationalize the different levels of engagement. This will allow the team to more fully understand the nature of work and resource needs for each level of engagement, for each project activity. In Canada, we recommend engaging with provincial SUPPORT Units10 whose role is to support and build capacity for patient engagement across the country. In the United States and United Kingdom, organisations, such as the Patient Centred Outcomes Research Institute8 and INVOLVE,24 respectively, are strong advocates of patient and public engagement and offer resources for researchers and patient partners. In discussion with our patient engagement lead (H. E.), we began to critically reflect on what levels were possible for the project activities selected in Step 2. For example, for the knowledge translation activities related to the qualitative phase of the study (known as the ‘barriers assessment’), we acknowledged that the team had sufficient resources to offer all levels of engagement except empowerment (not applicable as patient partners were not solely responsible for carrying out all knowledge translation activities). Ultimately, the team was able to offer all levels except empowerment for each project activity in that calendar year. Future years will require the same type of careful assessment of what resources are available to enact the researcher commitments at each level. We acknowledge that it can be challenging to fully articulate all the levels of engagement possible for each project activity, especially if the team does not have access to patient engagement expertise. The templates we provide herein are meant to practically assist teams in this regard. Further, we recommend adequate planning time for this step (and the one to follow). These steps require many conversations with research team members directly involved in each project activity, and with all patient partners as they will have useful feedback during the planning process. For example, during our planning process, patient partners asked whether training would be needed if they wanted to help create intervention materials. This feedback prompted our thinking about the theory behind the project's interventions and a recognition that meaningful contributions to developing interventions could only be possible with an understanding of the theory-informed intervention development.
3.1.4 Step 4: Describe the levels of patient engagement for researchers and patientsThis is perhaps the most important, tangible step in the creation of a PEP. Operationalizing the levels of engagement for each activity is critically important to allow researchers, research staff members and patient partners to fully understand what will be required from all parties to participate at each level of engagement. Ideally, this task will be carried out by a member of the research team who can describe each task or activity that was selected in Step 2, including the nature of the work, training requirements for the patients, facilitation needs of the research team, time commitments, resource needs and the goal of engagement at each of the levels. Budgeting for research support staff with dedicated time to work on planning patient engagement for the project and developing and enacting a PEP is crucial. The descriptions developed at this stage form the bulk of the PEP. For example, the last project activity for that year of the project was the development of intervention materials for the trial (Table 1). It is clear how greater levels of engagement require more time commitments from all team members (Table 1). At the levels of inform and consult, patient partners are asked mainly to review materials and provide written feedback at the consult level. However, at the collaborate level, patient partners are asked to help design materials, attend meetings where intervention materials will be reviewed, and attend a training session specific to the theoretical framework that guides intervention development. The researcher commitments and time required are also greater at this level.
As for Step 3, it can be challenging to operationalize the levels of engagement in a concrete way: research is unpredictable, timelines change and experienced researchers may not consciously think about the minutiae of tasks associated with various research activities. Ongoing conversations and brainstorming with relevant researchers and all patient partners are necessary to be as concrete as possible. It is the drafting of plans following such conversations and reviews by team members that highlight when something is unclear and generate questions. These questions ultimately help ensure that relevant information is included in the operationalization of the various levels.
3.1.5 Step 5: Review with project researchers and research support staffOnce the engagement levels for each activity have been fully operationalized, review those descriptions with researchers and research staff to discuss in detail and decide if the plan is feasible. Named team members should consider whether they can accommodate the researcher commitments outlined for each level of engagement and if the team has the resources to commit to all levels of engagement. At this stage, revisions to previous choices might be needed to narrow down the levels of engagement initially planned. For example, researchers may find more value in offering higher levels of engagement to patients for activities such as developing patient-facing materials than they would for monitoring day-to-day project operations.
3.1.6 Step 6: Review with patient partnersPatient partners also need to review the selected project activities and the levels of engagement that will be offered. If your research team does not yet have patient partners, we recommend reaching out to local patient engagement resources (such as the SUPPORT Units in Canada) or at the least, local public interest, community or advisory groups. At this stage, public feedback is needed about the clarity of activity descriptions and levels of engagement to ensure that the patient and researcher roles and responsibilities are easily understood and delineated. This really is critical. In our project, we were fortunate to have three lead patient partners from the very beginning of the project who could advise on all these steps thus far. As new partners joined the patient partner council, they also reviewed the plan. Their feedback on the specific project activities and levels of engagement for each resulted in numerous modifications to original descriptions. For example, patient partner review resulted in adding clarifying information about time commitment estimates, whether training would be necessary for any given project activities and a time estimate for it, and exactly which research team member would be responsible for following up with patient partners (and by when). These granular details matter.
3.1.7 Step 7: Survey your patient partners for their choicesOnce the entire research team, including partner partners, have reviewed and agreed on the PEP, patient partners are asked to choose how they want to be involved in the project activities outlined. The template itself functioned as a survey to allow patient partners an organized and formal method of identifying the project activities they were most interested in and at what level they wished to engage with those activities. The final version of the template (Table 1) was provided to each provincial patient partner, who recorded their preferences for each project activity. This allows both patients and researchers to retain a record of preferences for each patient partner that can be reviewed at any time throughout the project or revisited in the event of project changes. To this end, we recommend reviewing the PEP at least annually and as necessary in the event of unplanned changes to the project.
In our project, we were fortunate to have adequate levels of patient partner interest across all project activities and most levels of involvement. However, if we take seriously the notion of offering choice to patient partners and flexibility in how they wish to be involved (and at what level), then it is possible some project activities or levels of involvement may receive little or no interest from patient partners. If this is the case, but the team strongly believes a certain level of involvement is necessary for any given project activity, additional recruitment of patient partners might be needed. Again, we recommend reaching out to local patient engagement resources (such as the SUPPORT Units in Canada) or at the least, local public interest, community, patient or advisory groups with a clear description of the patient partner opportunity, including a description of the level of involvement desired. In the event that a desired level of involvement was not achieved for project activity, it is important to be transparent about this in any knowledge translation outputs and reflect on what the implications are.
3.2 A template for others to followBelow, a fillable PEP template is presented (Figure 2). It highlights the kind of information that should be crafted for each section of the plan, regardless of the research project. It provides a guide for others to follow and should encourage critical and deep reflection on specific project activities, possible levels of engagement for each activity and resources available to enact engagement.
3.2.1 Evaluating the planThe evaluation of patient engagement remains understudied, making it difficult to know what works best and when.5, 13, 14 The research team will evaluate the use of our PEP for year one before finalizing plans for subsequent project years. While the COVID-19 pandemic has slowed or halted data collection in all three study sites, an unforeseen benefit has been the luxury of time to create a detailed PEP and its evaluation. The team anticipates a mixed-method participatory evaluation, which some team members have already used successfully in evaluating patient-oriented research.14 We anticipate data collection through the use of online surveys and interviews, as well as in the collection of administrative, descriptive data (e.g., were follow up emails sent to patient partners as outlined in the plan). Key evaluation questions will potentially include:
Did all team members meet all commitments as outlined in the plan?
Was any training provided sufficient to enable team members to engage at the levels they preferred?
Were there any setbacks/lessons learned? What could be improved about patient engagement activities?
What was the patient and researcher experience of enacting the plan? What could we do differently?
Did other project sites use our template? Did patient partners share the plan with other project teams with whom they work?
3.3 Conclusions and lessons learnedEngaging with patient partners in health research is now largely accepted, and growing evidence supports its ability to improve research relevance, quality and outcomes.1, 11, 12, 14 Despite a growing number of tools and frameworks, however, there remains relatively little tangible guidance for how to operationalize the levels of possible engagement across health research activities. The detailed PEP provided here is a practical template that can be used widely by other health researchers and patient partners, customized to fit any specific project. We conclude with key lessons learned in the process of creating the plan.
First, Anticipate and budget for costs—The successful creation and implementation of a PEP requires targeted resources. In particular, a dedicated research staff person who coordinates the process is desired; budget for such research support at the funding application stage. Second, Be transparent—It is critical to identify those areas where patient engagement will not be practically possible in a project before creating the plan (e.g., members of our patient partner council who were recruited after funding was obtained had no opportunity to advise on study research questions or the theoretical framework that guides the study as these decisions were already made). Also identify if a particular level of engagement is not possible for all specific project activities (e.g., empowerment was not available for the project activities of staff hiring or financial management and reporting, nor for most research activities). Third, recognize that Specifics matter—Patient preferences can change when they are given additional information. For example, all three of our patient partners had initially chosen the collaborate level of involvement for many project activities in earlier verbal discussions and in earlier (less detailed) versions of the PEP. Through iterative drafts and reviews of the template, however, and at patient partners' request, we added additional information about training and time commitments. When this more precise information was included, our patient partners chose the consult or involve level of engagement instead. We believe this level of detail is important if we are to foster the levels of engagement patients truly wish. Cocreate—While we highly endorse cocreating PEPs with patient partners, we recommend researchers and research staff create the initial draft. These are the team members who best know specific project details and timelines, both of which are crucial to formulating a PEP. Once that initial draft is shared, however, patient partners are the team members who will then best be able to identify missing information gaps, and their feedback must drive all further iterations. Finally, Be flexible—If the COVID-19 pandemic has taught us anything, it is to be flexible. In this project, the pandemic did alter data collection activities, particularly in the Ontario and Alberta sites. It is important to discuss with patient partners whether alternative activities are available or update timelines regularly. Our council has continued to meet regularly throughout the pandemic, which has been important to maintain trust, communication and motivation. It also provides the opportunity for social support and brainstorming new ideas (e.g., creating potential knowledge translation outputs related to patient engagement, while waiting for data collection activities to resume in full).
In this paper, we aimed to provide guidance on how to codesign and operationalize a detailed PEP for any health research project. We not only include a fully worked example of a PEP using our trial as an example but also provide a fillable template for others to use in any health research project. We hope this guide can serve as a resource for research funders, researchers, providers and patient partners with the goal of advancing a more rigorous approach to the development and implementation of patient engagement in health research.
Comments (0)